Literature DB >> 11422258

Prevalence of extended-spectrum beta-lactamases in group-1 beta-lactamase-producing isolates.

C Varela1, A Oliver, T M Coque, F Baquero, R Cantón.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11422258     DOI： 10.1046/j.1198-743x.2001.00255.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  4 in total

1.  Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.

Authors:  J M Bell; J D Turnidge; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

2.  Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period.

Authors:  Rafael Cantón; Antonio Oliver; Teresa M Coque; María del Carmen Varela; José Claudio Pérez-Díaz; Fernando Baquero
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 3.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

4.  Quality control for beta-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain.

Authors:  Rafael Cantón; Elena Loza; María Del Carmen Conejo; Fernando Baquero; Luis Martínez-Martínez
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.